Lilayi Medical Limited 14753946 false 2023-03-24 2024-03-31 2024-03-31 The principal activity of the company is that of the provision of healthcare services. Digita Accounts Production Advanced 6.30.9574.0 true 14753946 2023-03-24 2024-03-31 14753946 2024-03-31 14753946 bus:Director1 2024-03-31 14753946 bus:Director1 1 2024-03-31 14753946 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 14753946 bus:Micro-entities 2023-03-24 2024-03-31 14753946 bus:AuditExemptWithAccountantsReport 2023-03-24 2024-03-31 14753946 bus:FilletedAccounts 2023-03-24 2024-03-31 14753946 bus:SmallCompaniesRegimeForAccounts 2023-03-24 2024-03-31 14753946 bus:RegisteredOffice 2023-03-24 2024-03-31 14753946 bus:Director1 2023-03-24 2024-03-31 14753946 bus:Director1 1 2023-03-24 2024-03-31 14753946 bus:PrivateLimitedCompanyLtd 2023-03-24 2024-03-31 14753946 countries:AllCountries 2023-03-24 2024-03-31 14753946 bus:Director1 1 2023-03-23 iso4217:GBP xbrli:pure

Registration number: 14753946

Lilayi Medical Limited

Unaudited Filleted Financial Statements

for the Period from 24 March 2023 to 31 March 2024

 

Lilayi Medical Limited

Contents

Company Information

1

Director's Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

3

 

Lilayi Medical Limited

Company Information

Director

Mr Henry Sibenge

Registered office

Apartment 516
55 Hooper Street
Sohowharf
Birmingham
West Midlands
B18 7AT

Accountants

Upton & Co Accountants Limited
Chartered Certified Accountants
182 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE

 

Lilayi Medical Limited

Director's Report for the Period from 24 March 2023 to 31 March 2024

The director presents his report and the financial statements for the period from 24 March 2023 to 31 March 2024.

This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

Incorporation

The company was incorporated on 24 March 2023.

Director of the company

The director who held office during the period was as follows:

Mr Henry Sibenge (appointed 24 March 2023)

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 14 November 2024
 

.........................................
Mr Henry Sibenge
Director

 

Lilayi Medical Limited

(Registration number: 14753946)
Balance Sheet as at 31 March 2024

2024
£

Current assets

9,789

Creditors: Amounts falling due within one year

(7,993)

Total assets less current liabilities

1,796

Accruals and deferred income

(720)

 

1,076

Capital and reserves

1,076

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Apartment 516
55 Hooper Street
Sohowharf
Birmingham
West Midlands
B18 7AT

These financial statements were authorised for issue by the director on 14 November 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

3

Related party transactions

Transactions with the director

2024

At 24 March 2023
£

Advances to director
£

At 31 March 2024
£

Mr Henry Sibenge

DLA

-

7,232

7,232

 

Lilayi Medical Limited

(Registration number: 14753946)
Balance Sheet as at 31 March 2024

For the financial period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 14 November 2024
 

.........................................
Mr Henry Sibenge
Director